However, the activation status of STAT3 has been reported to be inversely associated with the progression of distant metastases in prostate cancer [83], whereas conflicting reports suggest that it is an effective prognostic marker for prostate cancer [84]. This evidence concerns the gene STAT3 and prostate carcinoma.